Antibiotics and neutrophil function—potential immnnomodulating activities

Journal of Antimicrobial Chemotherapy

Volumn 31, Issue , 1993, Pages 23-33

  Gemmell, C G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; SUPEROXIDE;

BACTERIAL VIRULENCE; CELL FUNCTION; CHEMOTAXIS; CONFERENCE PAPER; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG TRANSPORT; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANTIBIOTICS; HUMAN; IN VITRO; LYMPHOCYTES; NEUTROPHILS; PHAGOCYTES;

EID: 0027502922     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/31.suppl_B.23     Document Type: Article

References (63)

1. Anderson, R. (1989). Erythromycin and roxithromycin potentiate human neutrophil locomatioo in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. Journal of Infectious Diseases 159, 966-73.
2. Anderson, R., Joonfc, G. & van Rensburg, C. E. J. (1986). An in-vitro investigation of the intracellular bioactivity of amoxicillin, clindamycin, and erythromycin for Staphylococcus aureus. Journal of Infectious Diseases 153, 593-600.
3. Anderson, R., Jooni, G. & van Rensburg, C. E. J. (1988). An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A56268, TE-031), a new macrolide antimicrobial agent. Journal of Antimicrobial Chemotherapy 22, 923-33.
4. Bassler, M., Blaschke, H., Just, M. & Daschner, F. D. (1982). Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes. Chemotherapy 28, 390-6.
5. Bersani, C., Santagada, T., Bertoletti, R., Fietta, A. & Gialdroni-Grassi, G. (1988). Fluoroquinolone derivatives-effects on neutrophil functional tests. In Proceedings of Mediterranean Conference on Chemotherapy. Cairo. 1988. pp. 222-3.
6. Capodicasa, E., Scaringi, L., Rosati, E., De Beilis, F., Sbaraglia, G., Marconi, P. et al. (1991). In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymophonuclear cell function. Journal of Antimicrobial Chemotherapy 27, 619-26.
7. Carlier, M. B., Zeneburgh, A. & Tulkens, P. M. (1987). Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cell. Journal of Antimicrobial Chemotherapy 20, Suppl. B. 47-56.
8. Carlone, N. A., Cuffini, A. M., Ferrero, M., TuDio, V. & Avetta, G. (1989). Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages. Journal of Antimicrobial Chemotherapy 23, 849-59.
9. Cates, L. K. & Caparas, L. (1981). Neutrophil (PMN) killing of Haemophilus influenzae b: Effect of pretreatment with ampicillin and chloramphenicol. In Program and Abstracts of the Twenty-First Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 658. American Society for Microbiology, Washington, DC.
10. Curnutte, J. T., Whitten, D. M. & Babior, B. M. (1974). Defective superoxide production by granulocytes from patients with chronic granulomatous disease. New England Journal of Medicine 290, 593-7.
11. Easmon, C. S. F. & Crane, J. P. (1984). Cellular uptake of clindamycin and lincomycm. British Journal of Experimental Pathology 65, 725-30.
12. Elsbach, P. & Weiss, J. (1985). Oxygen-dependent and oxygen-independent mechanisms of microbicidal activity of neutrophils. Immunology Letters 11, 159-63.
13. Ezer, G. & Soothill, J. F. (1974). Intracellular bactericidal effects of rifampidn in both normal and chronic granulomatous disease polymorphs. Archives of Disease in Childhood 49, 463-6.
14. Forsgren, A. & Schmeling, D. (1977). Effect of antibiotics of chemotaxis of human leukocytes. Antimicrobial Agents and Chemotherapy 11, 580-4.
15. Friedman, H. (1985). Synergism between the host defence mechanism and antibiotic treatment of bacteria. In Chemotherapy and Immunity (Pulverer, G. & Jeljaszewicz, J., Eds). Zentralblatt fur Bakteriologie, Suppl. 13, 105-13.
16. Friedman, H. & Warren, G. (1987). Antiobiotic modification of bacterial susceptibility to host immunity. In Antibiosis and Host Immunity (Szentivanyi, A., Friedman, H. & Gillissen, G., Eds), pp. 73-81. Plenum Press, New York.
17. Ganz, T., Selsted, M. E., Szldarek, D., Harwig, S. S., Daher, K. Bainton, D. F. et al. (1985). Defensins. Natural peptide antibiotics of human neutrophils. Journal of Clinical Investigation 76, 1427-35.
18. Gemmell, C. G. (1984). Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics. Journal of Antimicrobial Chemotherapy 13, 407-9.
19. Gemmell, C. G. & Amir, M. K. A. (1979). Effect of certain antibiotics on the formation of cellular antigens and extracellular products by group-A streptococci. In Pathogenic Streptococci (Parker, M. T., Ed.), pp. 67-8. Reed books, Chertsey, England.
20. Gemmell, C. G. & O'Dowd, A. (1983). Regulation of protein. A biosynthesis in Staphylococcus aureus by certain antibiotics: Its effect on phagocytosis by leukocytes. Journal of Antimicrobial Chemotherapy 12, 587-97.
21. Gemmell, C. G., Peterson, P. K., Schmeling, D., Kim, Y., Mathews, J., Wannamaker, C. et al.(1981). Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. Journal of Clinical Investigation 67, 1249-56.
22. Gemmell, C. G., Peterson, P. K., Schmeling, D., Mathews, J. & Quie, P. G. (1983). Antiobiotic- induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. European Journal of Clinical Microbiology 2, 327-34.
23. Gemmell, C. G. & Shibl, A. M. A. (1976). The control of toxin and enzyme biosynthesis in staphylococci by antibiotics. In Staphylococci and Staphylococcal Diseases (Jeljaszewicz, J., Ed.), pp. 657-64. Gustav Fischer Verlag, Stuttgart
24. Gladue, R. P. & Snider, M. E. (1990). Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrobial Agents and Chemotherapy 34, 1056-60.
25. Gnarpe, H. & Belsheim, J. (1981). Direct and indirect effects of antibiotics on granulocyte activity. Journal of Antimicrobial Chemotherapy 8, Suppl. C, 71-8.
26. Hand, W. L. & King-Thomson, N. L. (1989). The entry of antibiotics into human monocytes. Journal of Antimicrobial Chemotherapy 23, 681-9.
27. Hand, W. L., King-Thomson, N. L. & Steinberg, T. H. (1983). Interactions of antibiotics and phagocytes. Journal of Antimicrobial Chemotherapy 12, Suppl. C, 1-11.
28. Horwitz, M. A. & Silverstein, S. C. (1983). Intracellular multiplication of legionnaires* disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampicin. Journal of Clinical Investigation 71, 15-26.
29. Johnson, J. D., Hand, W. L., Francis, J. B., King-Thomson, N. & Corwin, R. W. (1980). Antibiotic uptake by alveolar macrophages. Journal of Laboratory and Clinical Medicine 95, 429-39.
30. KJempner, M. S. & Styrt, B. (1981). Clindamycin uptake by human neutrophils. Journal of Infectious Diseases 144, 472-9.
31. Labro, M. T., Amit, N., Babin-Chevaye, C. & Hakim, J. (1987). Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity. Journal of Antimicrobial Chemotherapy 19, 331-41.
32. Labro, M. T. & Babin-Chevaye, C. (1989a). Synergic bactfcricide de la josamycine et des polynuclfcaires neutrophiles humain In vitro. Pathologic Biologic 37, 329-34.
33. Labro, M. T. & Babin-Chevaye, C. (1989). Synergistic interaction of josamydn with human neutrophils bactericidal function in vitro. Journal of Antimicrobial Chemotherapy 24, 731-40.
34. Labro, M. T., Babin-Chevaye, C. & Hakim, J. (1986). Effects of cefotaxime and cefodizime on human granulocyte functions in vitro. Journal of Antimicrobial Chemotherapy 18, 233-7.
35. Labro, M. T. & el Benna, J. (1990a). Synergistic bactericidal interaction of josamydn with human neutrophils in vitro. Journal of Antimicrobial Chemotherapy 26, 515-24.
36. Labro, M. T. & el Benna, J. (1990A). Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro. Journal of Antimicrobial Chemotherapy 26, Suppl. C, 49-57.
37. Lagrange, P. H., Richet, H. & Escande, M. C. (1987). In vitro effects of sub-MICs of antibiotics on the antigenidty and immunogenicity of Pseudomonas aeruginosa. In Antibiosis and Host Immunity (Szentivanyi, A., Friedman, H. & Gillissen, G., Eds), pp. 51-62. Plenum Press, New York.
38. Lebish, I. J. & Moraski, R. M. (1987). Mechanisms of immunomodulation by drugs. Toxicologic Pathology 15, 338-5.
39. Lorian, V. & Gemmell, C. G. (1990). Effect of low antibiotic concentrations on bacteria: Effects on ultrastructure, virulence, and susceptibility to immunodefenses. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed.), pp. 493-555. Williams & Wilkins, Baltimore, MD.
40. Mandell, L. A. (1982). Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbiddal function of the polymorphonuclear leukocyte. Reviews of Infectious Diseases 4, 683-97.
41. Mandell, G. L. & Vest, T. K. (1972). Killing of intraleukocytic Staphylococcus aureus by rifampidn: In-vitro and in-vivo studies. Journal of Infectious Diseases 125, 486-90.
42. Milatovic, D. (1982). Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus. European Journal of Clinical Microbiology 1, 97-101.
43. Miller, M. F., Martin, J. R., Johnson, P., Ulrich, J. T., Rdzok, E. J. & Billing, P. (1984). Erythromydn uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromydn in killing ingested Legionella pneumophila. Journal of Infectious Diseases 149, 714-8.
44. Oleske, J. M. (1984). Effects of antimicrobials on host defence mechanism. Journal of Antimicrobial Chemotherapy 13, 413-5.
45. Prokesch, R. C. & Hand, W. L. (1982). Antibiotic entry into human polymorphonudear leukocytes. Antimicrobial Agents and Chemotherapy 21, 373-80.
46. Raponi, G., Vreede, R. W., Rozenberg-Arska, M., Hoepelman, I. M., Keller, N. & Verhoef, J. (1989). The influence of subminimal inhibitory concentrations of netilmidn and ceftriaxone on the interaction of Escherichia coli with host defences. Journal of Antimicrobial Chemotherapy 23, 565-76.
47. Ritts, R. E. (1990). Antibiotics as biological response modifiers. Journal of Antimicrobial Chemotherapy 26, Suppl. C, 31-6.
48. Shafer, W. M., Martin, L. E. & Spitznagei, J. K. (1986). Late intraphagosoma! hydrogen ion concentration favors the in vitro antimicrobial capadty of a 37-kilodalton cationic granule protdn of human neutrophil granulocytes. Infection and Immunity 53, 651-5.
49. Silva, J., Dembinski, S. & Schaberg, D. (1983). Effects of subinhibitory antibiotics on bacteriddal activity of chronic granulomatous disease granulocytes in vitro. Journal of Antimicrobial Chemotherapy 12, Suppl. C. 21-7.
50. Smith, D. L. & Rommel, F. (1977). A rapid micromethod for the simultaneous determination of phagocytic-microbioddal activity of human peripheral blood leukocytes in vitro. Journal of Immunological Methods 17, 241-7.
51. Talmadge, J. E., Oldham, R K. & Fidier, I. J. (1984). Practical considerations for the establishment of a screening procedure for the assessment of biological response modifiers. Journal of Biological Response Modifiers 3, 88-109.
52. van den Broek, P. T., Buys, L. F., van den Barselaar, M. T., Leijh, P. C. & van Furth, R. (1986). Influence of human monocytes on the antibacterial activity of kanamydn and gentamidn for Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 29, 1032-9.
53. Van der Auwera, P. (1990). In-vitro tests of the functions of phagocytic cells and their interaction with antimicrobial agents: A critical review. Journal of Antimicrobial Chemotherapy16, 168-73.
54. Van der Auwera, P., Matsumoto, T. & Husson, M. (1988). Intraphagocytic penetration of antibiotics. Journal of Antimicrobial Chemotherapy 22, 185-92.
55. van Rensberg, C. E. J., Anderson, R., Joon6, G., van der Merwe, A. J. & van Rensberg, A. J. (1981). Effects of erythromycin on cellular and humoral immune functions in vUro and in vivo. Journal of Antimicrobial Chemotherapy 8, 467-74.
56. van Rensberg, C. E. J., Joon4, G. & Anderson, R. (1989). An in vitro investigation of the intraphagocytic bioactivity of difloxadn, ciprofloxacin, pefloxacin and fleroxacin. Chemotherapy 35, 273-7.
57. van Rensberg, C. E. J., Jooni, G. & Anderson, R. (1990). Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxadn, ciprofloxacin, pefloxacin and fieroxadn in the intraphagocytic eradication of Staphylococcus aureus. Journal of Medical Microbiology 32, 15-7.
58. Veringa, E. M., Box, A., Rozenberg-Arska, M. & Verhoef, J. (1988). Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains. Drugs Under Experimental and Clinical Research 14, 1-8.
59. Veringa, E. M., Ferguson, D. A., Lambe, D. W. & Verhoef, J. (1989). The role of glycocalyx in surface phagocytosis of Bacteroides spp. in the presence and absence of clindamydn. Journal of Antimicrobial Chemotherapy 23, 711-20.
60. Veringa, E. M. & Verhoef, J. (1986). Influence of subinhibitory concentrations of dindamycin on opsonophagocytosis of Staphylococcus aureus, a protdn A-dependent process. Antimicrobial Agents and Chemotherapy 30, 796-7.
61. Viano, I., Martmetto, P., Valtz, A., Santiano, M. & Barbaro, S. (1979). Variability of immune response induced by bacteria treated with subminimal inhibitory concentrations of fosfomydn. Reviews of Infectious Diseases 1, 858-61.
62. Vosbeck, K., James, P. R. & Zimmermann, W. (1984). Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. Antimicrobial Agents and Chemotherapy 25, 735-41.
63. Yourtree, E. L. & Root, R. K. (1982). Antibiotic-neutrophil interactions in microbial killing. In Advances in Host Defense Mechanisms (Gallin, J. I. & Faud, A. S., Eds), pp. 187-209. Raven Press, New York.